dc.contributor.author | Palace, Jacqueline | |
dc.date.accessioned | 2020-12-23T10:44:33Z | |
dc.date.available | 2020-12-23T10:44:33Z | |
dc.date.issued | 2020-08 | |
dc.identifier.citation | Ruth Geraldes , Maciej Juryńczyk, Giordani Rodrigues dos Passos, Alexander Pichler, Karen Chung, Marloes Hagens, Serena Ruggieri, Cristina Auger, Jaume Sastre-Garriga, Christian Enzinger, Declan Chard, Frederik Barkhof, Claudio Gasperini, Alex Rovira, Gabriele DeLuca, Jacqueline Palace. The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease. Multiple sclerosis journal, First Published August 6, 2020. | en |
dc.identifier.issn | 14770970 | |
dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/681 | |
dc.description | https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). | en |
dc.description.abstract | Background:
Differentiating multiple sclerosis (MS) from vascular risk factor (VRF)-small vessel disease (SVD) can be challenging.
Objective and Methods:
In order to determine whether or not pontine lesion location is a useful discriminator of MS and VRF-SVD, we classified pontine lesions on brain magnetic resonance imaging (MRI) as central or peripheral in 93 MS cases without VRF, 108 MS patients with VRF and 43 non-MS cases with VRF.
Results:
MS without VRF were more likely to have peripheral pons lesions (31.2%, 29/93) than non-MS with VRF (0%, 0/43) (Exp(B) = 29.8; 95% confidence interval (CI) = (1.98, 448.3); p = 0.014) but there were no significant differences regarding central pons lesions between MS without VRF (5.4%, 5/93) and non-MS with VRF patients (16.3%, 7/43) (Exp(B) = 0.89; 95% CI = (0.2, 3.94); p = 0.87). The presence of peripheral pons lesions discriminated between MS and VRF-SVD with 100% (95% CI = (91.8, 100)) specificity. The proportion of peripheral pons lesions in MS with VRF (30.5%, 33/108) was similar to that seen in MS without VRF (31.2%, 29/93, p = 0.99). Central lesions occurred in similar frequency in MS with VRF (8.3%, 9/108) and non-MS with VRF (16.3%, 7/43, p = 0.15).
Conclusion:
Peripheral pons lesion location is a good discriminator of MS from vascular lesions. | en |
dc.description.sponsorship | Supported by the NIHR | en |
dc.description.uri | https://doi.org/10.1177/1352458520943777 | en |
dc.language.iso | en | en |
dc.subject | Multiple Sclerosis | en |
dc.title | The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease | en |
dc.type | Article | en |